ANI PHARMACEUTICALS, INC Increase (Decrease) in Other Operating Liabilities
ANI PHARMACEUTICALS, INC (ANIP) reported Increase (Decrease) in Other Operating Liabilities of $1.34 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2018-11-06
- ANI PHARMACEUTICALS, INC increase (decrease) in other operating liabilities for the quarter ending 2018-09-30 was $1.02M, a 43.14% decline year-over-year.
- ANI PHARMACEUTICALS, INC increase (decrease) in other operating liabilities for the quarter ending 2018-06-30 was -$749.00K.
- ANI PHARMACEUTICALS, INC increase (decrease) in other operating liabilities for the quarter ending 2018-03-31 was $1.07M, a 7.92% decline year-over-year.
- ANI PHARMACEUTICALS, INC increase (decrease) in other operating liabilities for the quarter ending 2017-12-31 was -$1.17M.
- ANI PHARMACEUTICALS, INC increase (decrease) in other operating liabilities for fiscal 2017 was $644.00K, a 31.49% decline from fiscal 2016.
- ANI PHARMACEUTICALS, INC increase (decrease) in other operating liabilities for fiscal 2016 was $940.00K, a 944.44% increase from fiscal 2015.
- ANI PHARMACEUTICALS, INC increase (decrease) in other operating liabilities for fiscal 2015 was $90.00K, a 62.50% decline from fiscal 2014.
- ANI PHARMACEUTICALS, INC increase (decrease) in other operating liabilities for fiscal 2014 was $240.00K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 3 month as first filed | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 6 month as first filed | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 9 month as first filed | Increase (Decrease) in Other Operating Liabilities 12 month | Increase (Decrease) in Other Operating Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-09-30 | $1.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $275.00K derived: sum of 2 quarters · filed 2018-11-06 | $1.34M 10-Q · filed 2018-11-06 | $174.00K derived: sum of 4 quarters · filed 2018-11-06 | ||||
| 2018-06-30 | -$749.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $320.00K 10-Q · filed 2018-08-07 | -$850.00K derived: sum of 3 quarters · filed 2018-08-07 | $951.00K derived: sum of 4 quarters · filed 2018-11-06 | ||||
| 2018-03-31 | $1.07M 10-Q · filed 2018-05-08 | -$101.00K derived: sum of 2 quarters · filed 2018-05-08 | $1.70M derived: sum of 3 quarters · filed 2018-11-06 | $552.00K derived: sum of 4 quarters · filed 2018-11-06 | ||||
| 2017-12-31 | -$1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $631.00K derived: sum of 2 quarters · filed 2018-11-06 | -$517.00K derived: sum of 3 quarters · filed 2018-11-06 | $644.00K 10-K · filed 2018-02-27 | ||||
| 2017-09-30 | $1.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $653.00K derived: sum of 2 quarters · filed 2018-11-06 | $1.81M 10-Q · filed 2018-11-06 | $100.00K derived: sum of 4 quarters · filed 2018-11-06 | ||||
| 2017-06-30 | -$1.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $13.00K 10-Q · filed 2018-08-07 | -$1.70M derived: sum of 3 quarters · filed 2018-08-07 | -$1.71M derived: sum of 4 quarters · filed 2018-08-07 | ||||
| 2017-03-31 | $1.16M 10-Q · filed 2018-05-08 | -$553.00K derived: sum of 2 quarters · filed 2018-05-08 | -$557.00K derived: sum of 3 quarters · filed 2018-05-08 | $991.00K derived: sum of 4 quarters · filed 2018-05-08 | ||||
| 2016-12-31 | -$1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$1.72M derived: sum of 2 quarters · filed 2018-02-27 | -$170.00K derived: sum of 3 quarters · filed 2018-02-27 | $940.00K 10-K · filed 2018-02-27 | ||||
| 2016-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $1.54M derived: sum of 2 quarters · filed 2017-11-02 | $2.65M 10-Q · filed 2017-11-02 | $4.11M 10-Q · filed 2016-11-03 | $773.00K derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-06-30 | $1.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $2.66M 10-Q · filed 2017-08-03 | $3.32M 10-Q · filed 2016-08-04 | $777.00K derived: sum of 3 quarters · filed 2018-02-27 | $2.35M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-03-31 | $1.11M 10-Q · filed 2017-05-04 | $3.96M 10-Q · filed 2016-05-05 | -$771.00K derived: sum of 2 quarters · filed 2018-02-27 | $805.00K derived: sum of 3 quarters · filed 2018-02-27 | $200.00K derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2015-12-31 | -$1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$305.00K derived: sum of 2 quarters · filed 2018-02-27 | -$910.00K derived: sum of 3 quarters · filed 2018-02-27 | $90.00K 10-K · filed 2018-02-27 | $1.16M 10-K · filed 2016-02-23 | |||
| 2015-09-30 | $1.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $971.00K derived: sum of 2 quarters · filed 2016-11-03 | $1.97M 10-Q · filed 2016-11-03 | $1.42M 10-Q · filed 2015-11-03 | $1.34M derived: sum of 4 quarters · filed 2017-03-02 | |||
| 2015-06-30 | -$605.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $395.00K 10-Q · filed 2016-08-04 | $175.00K 10-Q · filed 2015-08-04 | -$235.00K derived: sum of 3 quarters · filed 2017-03-02 | $513.00K derived: sum of 4 quarters · filed 2017-03-02 | |||
| 2015-03-31 | $1.00M 10-Q · filed 2016-05-05 | $370.00K derived: sum of 2 quarters · filed 2017-03-02 | $1.12M derived: sum of 3 quarters · filed 2017-03-02 | $1.26M derived: sum of 4 quarters · filed 2017-03-02 | ||||
| 2014-12-31 | -$630.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $118.00K derived: sum of 2 quarters · filed 2017-03-02 | $261.00K derived: sum of 3 quarters · filed 2017-03-02 | $240.00K 10-K · filed 2017-03-02 | $1.65M 10-K · filed 2015-02-23 | |||
| 2014-09-30 | $748.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | $891.00K derived: sum of 2 quarters · filed 2015-11-03 | $870.00K 10-Q · filed 2015-11-03 | $2.98M 10-Q · filed 2014-11-10 | $1.19M derived: sum of 4 quarters · filed 2016-02-23 | |||
| 2014-06-30 | $143.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $122.00K 10-Q · filed 2015-08-04 | -$12.00K 10-Q · filed 2014-08-07 | $437.00K derived: sum of 3 quarters · filed 2016-02-23 | $658.00K derived: sum of 4 quarters · filed 2016-02-23 | |||
| 2014-03-31 | -$21.00K 10-Q · filed 2015-05-05 | -$209.00K 10-Q · filed 2014-05-12 | $294.00K derived: sum of 2 quarters · filed 2016-02-23 | $515.00K derived: sum of 3 quarters · filed 2016-02-23 | $51.00K derived: sum of 4 quarters · filed 2016-02-23 | |||
| 2013-12-31 | $315.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $536.00K derived: sum of 2 quarters · filed 2016-02-23 | $72.00K derived: sum of 3 quarters · filed 2016-02-23 | -$67.00K 10-K · filed 2016-02-23 | $25.00K 10-K · filed 2014-02-28 | |||
| 2013-09-30 | $221.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$243.00K derived: sum of 2 quarters · filed 2014-11-10 | -$382.00K 10-Q · filed 2014-11-10 | -$382.86K 10-Q · filed 2013-11-07 | -$365.27K derived: sum of 4 quarters · filed 2014-11-10 | |||
| 2013-06-30 | -$464.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$603.00K 10-Q · filed 2014-08-07 | -$599.39K 10-Q · filed 2013-08-09 | -$586.27K derived: sum of 3 quarters · filed 2014-08-07 | -$225.07K derived: sum of 4 quarters · filed 2014-08-07 | |||
| 2013-03-31 | -$139.00K 10-Q · filed 2014-05-12 | -$122.27K derived: sum of 2 quarters · filed 2014-05-12 | $238.93K derived: sum of 3 quarters · filed 2014-05-12 | |||||
| 2012-12-31 | $16.73K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $377.93K derived: sum of 2 quarters · filed 2014-02-28 | $205.00K 10-K · filed 2014-02-28 | |||||
| 2012-09-30 | $361.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $188.27K 10-Q · filed 2013-11-07 | ||||||
| 2012-06-30 | -$172.93K 10-Q · filed 2013-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |